Saturday, October 27

6:45 am – 6:00 pm

Registration Open

6:45 am – 8:00 am

Product Theater

201

Product Theater

Sponsored by Avadel Pharmaceuticals

8:00 am – 12:00 nn

Certification Exam

Preregistration is required. The certification application is available at cbuna.org, or call C-NET at 800-463-0786 for details. All applications must be postmarked by August 31, 2018.

8:05 am – 8:20 am

Remarks and Awards

8:25 am – 9:25 am

General Session


210

“Do You have a Smartphone?” The Use of Technology for Management of Urology Patients

1 contact hour

Gina Powley, MSN, ANP-BC

With the advancing use of technology (smartphones/smartpads), urology team members, patients and families have different options on how to monitor patient progress and management of common urology ailments. This presentation will give an overview on the use of different urology apps for different members on the urology team. Pros, cons and uses of the apps, as well as the financial

9:30 am – 11:00 am

Exhibits Open/Coffee Break/Posters

11:05 am – 12:05 pm

Concurrent Sessions

221

Pediatric Enuresis Education Sessions: Addressing the Nocturnal Enuresis Nightmare

1 contact hour

Melissa Young, MSN, RN, CPNP

Nocturnal enuresis affects approximately 6 million children in the United States each year. Due to the high number of children affected and the high number of nocturnal enuresis referrals to our pediatric urology clinic, families experienced an increased wait time for provider appointments, resulting in dissatisfaction and delay in treatment. In an attempt to address this issue and begin treatment as soon as possible, we implemented Pediatric Enuresis Education Sessions.


222

The Art of Patient Teaching (Or is It?)

1 contact hour

Cheryl LeCroy, MSN, RN

Often, patient education is overlooked or done quickly for many reasons. Patient education is a fundamental aspect of patient care and yet poor education is one of the most common sources of patient complaints both in and out of the hospital. Ensuring patient understanding of their health condition is extremely important and can improve outcomes, adherence to the plan of care and patient safety. Patient education concepts and creative ways to interject patient teaching in encounters with urologic patients will be discussed.


223

Sacral Nerve Stimulation (SNS) Programming and Troubleshooting

1 contact hourPF

Lori Guelman, MSN, RN-FNP-BC

The SNS is an implantable neurostimulator device indicated for OAB, UUI, urinary retention and fecal incontinence. This talk will review SNS and discuss indications for reprogramming as well as different ways to troubleshoot in the office.


224

Gender-Affirming Reconstructive Surgery

1 contact hourAPN

Jonathan Witten, MD

An overview of gender-affirming reconstructive surgery and perioperative considerations will be reviewed.

12:15 pm – 1:30 pm

Product Theater

230

A Treatment Option for Castration-Resistant Prostate Cancer (CRPC)

Anne Zobec, RN, MS, AOCNP

Sponsored by Astellas Pharma US, Inc. and Pfizer Oncology

1:35 pm – 2:35 pm

Concurrent Sessions

241

Nursing Interventions for Male Urethral Stricture Patients

1 contact hour

Mary West, MSNE, RN, CURN

This presentation aims to provide the urology nurse with a broad review of nursing interventions relating to care of male urethral stricture patients. Initial assessment through postoperative, follow-up care, will be presented, including radiographic/case studies for various stricture locations, surgery techniques, and concomitant nursing interventions.


242

AUA Guideline Update on Management of Small Renal Masses

1 contact hour

Vitaly Margulis, MD

During this session, we will discuss the newest recommendations of management and follow up of small renal masses, highlighting changes in the most recent AUA Guidelines. Additional focus on practical concerns and decisions made in real-life clinical practice.


243

Asymptomatic Microscopic Hematuria in Women

1 contact hourPF

Shawn Menefee, MD

Asymptomatic microscopic hematuria (AMH) is a common finding and has been considered an important clinical sign of urinary tract malignancy. The definition and guidelines of AMH have changed over the years. Much of the evidence is based on data from male patients and the risk of urinary tract malignancy may be less in women than in men. Women specific conditions may lead to increased incidence of AMH. Likewise, primary care providers appear not to refer many women with AMH. We will review guidelines and consider how recent evidence is changing practice.


244

Role of Imaging in Stone Disease

1 contact hourAPN

Margaret Pearle, MD

Imaging is the cornerstone of the diagnosis of kidney stones and it plays an important role in surgical planning, surgical management and follow-up of patients with kidney stones. The different imaging modalities available for diagnosing stones, their risks and benefits and their indications for use in the diagnosis and treatment of patients with kidney stones will be presented.

2:40 pm – 3:40 pm

Concurrent Sessions

251

Cancer Genetics, It’s Not Just BRCA1/2 Anymore

1 contact hour

Brian Reys, MS, CGC

Delve into the world of hereditary cancer predisposition syndromes in this session designed to update clinicians on the ins and outs of cancer genetics. Together we will earn how to identify patients at high risk, discuss clinical advances in genetic testing, and evaluate the utility of direct-to-consumer genetic testing. We will critically analyze the availability and service delivery of genetic testing and share tools to help shape the landscape of your practice.


252

Kidney Stones: The Essentials of Medical and Surgical Management

1 contact hour

Margaret Pearle, MD

Kidney stones are one of the most common benign urologic conditions, affecting nearly 1 in 11 individuals at some time in their lives. The epidemiology of kidney stones, management of the patient presenting with an acute stone, and surgical treatment options for patients with kidney stones will be presented in this session.


253

Genitourinary Syndrome of Menopause: Medical Management and Procedural Therapies

1 contact hourPF

Elizabeth Evans, MD

In 2014, the new term genitourinary syndrome of menopause (GSM) was introduced to encompass the symptoms associated with the loss of estrogen that occurs with menopause. These symptoms of atrophy affect the vulva, vagina, bladder and urethra. Patients can experience symptoms such as pain, sexual dysfunction, vaginal bleeding and recurrent urinary tract infections. In addition to vaginal estrogen, we will review the non-estrogen medications and in-office procedures available to treat GSM.


254

AUA Update: Benign Prostatic Hyperplasia and Postoperative Management

1 contact hourAPN

Michelle Lajiness, FNP-BC

The management of BPH will be reviewed using the AUA Guidelines. Included in this discussion will be prevalence, signs and symptoms, appropriate H&P and diagnostic testing. Various treatments including watchful waiting, medical therapy, minimally invasive therapies and surgical procedures will be discussed. A special emphasis will be placed on postoperative care reviewing potential complications and interventions.

3:45 pm – 4:45 pm

Concurrent Sessions

261

Assessing Clinical Competency of the Urology Nurse

1 contact hour

Glenn Sulley, BS, RN, CURN

Evaluating urology-specific clinical competency of a professional urology nurse is a continuing process. The use of uniquely developed competency assessment tools will be discussed. These proficiencies have proven to be very valuable in our urology practice and have become an essential part of our nurse’s annual performance appraisals. Experience with this competency protocol, our rating system, validation, and evaluation practice for each of our specific competencies will be shared.


262

Nocturia: Advanced Concepts for the Urologic and Urogynecologic Specialist

1 contact hour

Mikel Gray, FNP, PNP, CUNP, CCCN, FAANP, FAAN

Nocturia, defined as interruption of sleep owing to a desire to urinate, is one of the most common and most bothersome lower urinary tract symptoms. This lecture will review the epidemiology, pathophysiology, evaluation and management of nocturia focusing on urologic specialty and advanced practice.


263

Treating Pelvic Floor Dysfunction with Pelvic Floor Physical Therapy

1 contact hourPF

Stephanie Prendergast, MPT

The participants of this lecture will understand the evidence behind physical therapy diagnosis and treatment for pelvic floor disorders and understand the components of pelvic floor physical therapy evaluation and treatment. Clinicians will learn how to do a basic pelvic floor examination and suggestions will be made about how to work within an interdisciplinary treatment model. Diagnoses covered will include vulvodynia, interstitial cystitis, pudendal neuralgia, CPPS and stress urinary incontinence and pelvic organ prolapse.


264

Bladder Cancer: From Basics to New Frontiers

1 contact hourAPN

Leanne Schimke, MSN, FNP-C, CRNP, CUNP

After decades without significant advances in bladder cancer treatment, numerous new agents that help to reactivate the patient’s own antitumor response have been approved. This presentation will cover bladder cancer from NMIBC, MIBC to metastatic bladder cancer incorporating intravesical treatments, new therapies, relevant guidelines and evidence-based therapies. It is important to understand the pathophysiology of bladder cancer, long-term sequalae, and the rationale for the various therapies.

4:50 pm – 5:50 pm

Concurrent Sessions

271

Congenital Anomalies of the Female Genitourinary Tract – Update on Treatment of Disorders of Sex Development (DSD) and Their Impact on Sexuality and Fertility

1 contact hour

Valre Welch, MSN, CPNP

Issues affecting sexuality can begin as early as embryonic life. DSD can greatly impact both sexuality and fertility. A review of medical management and possible surgical interventions in patients with Mayer-Rokitansky-Kuster-Hauser Syndrome (MRKHS), complete androgen insensitivity syndrome (CAIS) and congenital adrenal hyperplasia (CAH) will be presented. There have been significant advancements in the management of these patients. These are complex adolescent girls and young adults requiring provider support and understanding.


272

Urology Briefs

1 contact hour

This session is a series of short presentations on focused urology topics. The presentations will be informative and eye-opening.


273

Advanced Interpretation of Urodynamics for the Experienced Specialist and Advanced Practice Provider

1 contact hourPF

Mikel Gray, PhD, PNP, CUNP, CCCN, FAANP, FAAN

This case-based, interactive session will focus on advanced concepts in urodynamic testing and interpretation of their clinical implications. Designed for the experienced specialist or advanced practice provider, the cases presented in this session will challenge even the most experienced clinician seeking to advance their skills in interpretation of urodynamic findings. Cases will include multichannel and video urodynamic testing, pressure flow and contractility nomograms, and urethral pressure profilometry.


274

Contemporary Policy and Practice Issues for the Nurse Practitioner in Urology Specialty Practice

1 contact hourAPN

Susanne Quallich, PhD, ANP-BC, NP-C, CUNP, FAANP

Policy and practice issues for the NP working in urology practice will be presented. This session will include discussion of the AUA/SUNA perspective on the NP role in urology, the influence of the APRN consensus model, and introduce methods to advance the NP role in urology as a way to meet the aging population’s need for specialty urology care. Issues relative to education/certification, legal issues, present and future regulatory issues, and present and future reimbursement issues will also be examined.

< View the schedule for Friday

View the schedule for Sunday <